Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Optimi HealthOPTHF 47 Earnings per Share (Diluted) is $-0.04 as of Mar. 2026. GuruFocus rates OPTHF with a GF Score™ of 47/100 and a GF Value™ of $0.21. The stock has 4 warning signs investors should review. Among 787 Drug Manufacturers companies, Optimi Health ranks better than 60.61% on this metric.
Optimi Health's EPS (Basic) for the
three
months ended in Mar. 2026 was $0.00.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.04.
During the past 3 years, the average EPS without NRIGrowth Rate was 15.30% per year.
During the past 6 years, Optimi Health's highest 3-Year average EPS without NRI Growth Rate was 16.40% per year. The lowest was 15.30% per year. And the median was 15.85% per year.
Optimi Health (OTCPK:OPTHF) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Optimi Health Earnings per Share (Diluted) Related Terms
Optimi Health Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Optimi Health's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OPTHF vs ZTS: Earnings per Share (Diluted) Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Optimi Health's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Optimi Health PE Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Optimi Health's PE Ratio distribution charts can be found below:
* The bar in red indicates where Optimi Health's PE Ratio falls into.
Optimi Health Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Optimi Health's Earnings Per Share (Diluted) for the fiscal year that ended in Sep. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.04
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $-0.04 mean?
Optimi Health (OPTHF) has a Earnings per Share (Diluted) of $-0.04 as of Mar. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Optimi Health and its competitors. According to the industry distribution chart, Optimi Health ranks #310 out of 787 companies in the Drug Manufacturers industry, placing it in the top 39.4%.
Is Optimi Health's Earnings per Share (Diluted) too high?
Optimi Health's current Earnings per Share (Diluted) is $-0.04. Based on the distribution chart, Optimi Health ranks #310 out of 787 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Optimi Health has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Optimi Health's Earnings per Share (Diluted) compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Optimi Health ranks #310 out of 787 companies for Earnings per Share (Diluted). This puts Optimi Health in the upper half of its industry. The industry median Earnings per Share (Diluted) is 9.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Drug Manufacturers company?
The median Earnings per Share (Diluted) among Drug Manufacturers companies is 9.70, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Optimi Health and its competitors. For the Drug Manufacturers industry, the median Earnings per Share (Diluted) is 9.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Optimi Health's current Earnings per Share (Diluted) is $-0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optimi Health stock overvalued right now?
Optimi Health (OPTHF) has a current Earnings per Share (Diluted) of $-0.04. The stock's GF Value™ is $0.21, compared to a current price of $0.24 — trading 12% above its estimated fair value. The current Earnings per Share (Diluted) is $-0.04. Optimi Health's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Optimi Health (OPTHF), the current Earnings per Share (Diluted) is $-0.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Optimi Health (OPTHF) Overvalued in 2026?
Based on GuruFocus' analysis, Optimi Health stock appears to be overvalued.
The current stock price of $0.24 is trading 12% above its estimated GF Value™ of $0.21.
Key valuation signals for OPTHF:
Earnings per Share (Diluted): $-0.04
GF Value™: $0.21 vs. price of $0.24 (12% above fair value)
No single metric tells the full story. See the OPTHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.
47GF Score
Get the complete analysis for OPTHF
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OPTHF has been successfully added to your 
